Drug Type Bispecific antibody |
Synonyms |
Target |
Action- |
Mechanism LRRC32 inhibitors(Transforming growth factor beta activator LRRC32 inhibitors), TGF-β1 inhibitors(Transforming growth factor beta 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseUnknown |
First Approval Date- |
Regulation- |





